Avantor Inc

Avantor Inc

Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.

Stock Performance Snapshot

Buy

Analyst Rating

Analysts recommend buying Avantor's stock, expecting it to rise significantly in value.

Above Average

Financial Health

Avantor Inc is performing well, showing strong revenue and cash flow generation, with decent profit margins.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring AVTR

Pharma Onshoring Boom: Investment Risk Considerations

Pharma Onshoring Boom: Investment Risk Considerations

AstraZeneca is building a major new manufacturing plant in the U.S., responding to policy pressures for domestic production. This signals a broader trend of onshoring pharmaceutical manufacturing, creating opportunities for companies that build and equip these advanced facilities.

Published: October 10, 2025

Explore Basket
Pharma's American Reshoring Wave

Pharma's American Reshoring Wave

AstraZeneca is investing $50 billion to expand its U.S. manufacturing, partly in response to trade tariffs. This move could spark a wave of similar onshoring efforts, creating opportunities for companies that build, equip, and supply the growing domestic biopharmaceutical industry.

Published: July 23, 2025

Explore Basket

Why You’ll Want to Watch This Stock

📈

Steady Consumables Demand

Recurring purchases of lab reagents and disposables can provide reliable revenue, though end-market cycles and budget shifts may affect volumes.

🌍

Global Footprint

Broad geographic reach helps diversify customers across pharma, academia and industry, but exposes the business to currency and regional regulatory risks.

Operational Levers

Efficiency, pricing on speciality products and integration of acquisitions can lift margins, though execution and cost pressures are ongoing considerations.

Why invest with Nemo?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

ABT

Abbott Laboratories

Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.

TMO

Thermo Fisher Scientific, Inc.

Thermo Fisher provides a range of services and products that help customers advance their research, solve complex analytical challenges, improve patient diagnostics, and increase laboratory productivity.

ISRG

Intuitive Surgical, Inc.

A healthcare company that develops, manufactures, and markets robotic-assisted surgical systems for procedures in multiple specialties

Frequently asked questions